UNSPSC 51322402: Benzmalecene

This classification denotes an anti-lipidemic agent with the molecular formula C20H19Cl2NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6ET4K804XA, chemically known as n-(2,3-bis(p-chlorophenyl)-1-methylpropyl)maleamic acid (alpha-form) but generally known as benzmalecene, which bears US NIH Compound Identifier 6436094. European Medicines Agency schedules Benzmalecene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05752MIG.

UNSPSC 51322402 Benzmalecene is a Commodity code that in recent state and local procurement activity covers advanced life support medications and multi-source generic pharmaceuticals supplied to healthcare delivery systems, emergency services, and pharmacy benefit programs operated or overseen by government entities. The scope of work under this code reflects direct procurement of finished pharmaceutical products — specific injectable medications such as epinephrine, labetalol, adenosine, and diltiazem for emergency medical services; generic oral and parenteral drugs for institutional and retail pharmacy networks; and over-the-counter products distributed through state and local healthcare facilities. Issuing bodies include municipal fire and rescue departments, state health and human services agencies, and cooperative purchasing alliances that aggregate demand across multiple state and local jurisdictions. The City of Tampa Fire Rescue and the Texas Health and Human Services Commission and Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) have posted recent opportunities under related pharmaceutical procurement activity. Vendors typically must demonstrate cGMP certification, Drug Supply Chain Security Act compliance, established relationships with authorized pharmaceutical wholesalers, and ability to maintain required expiration dates and shelf life minimums.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa issued IFB 26P00188 in April 2026, seeking four injectable Advanced Life Support Medications for Tampa Fire Rescue with a response deadline of April 8, 2026 and an estimated contract value of $40,000, with a 5 percent bid discount available for Small Local Business Enterprise participation and a one-year base term plus renewal options. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 through MMCAP in January 2026, establishing multi-award contracts for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota and Oregon, with a March 26, 2026 response deadline and July 1, 2026 contract effective date. The Texas Health and Human Services Commission posted RFI HHS0017013 in March 2026 as a preliminary market-intelligence solicitation regarding direct-to-manufacturer prescription fulfillment capabilities, with an April 3, 2026 response deadline and no specific budget or award value disclosed.